Nu-Med Plus, Inc.

Nu-Med Plus, Inc.

NUMD - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$902.32K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nu-Med Plus, Inc.Nu-Med Plus, Inc.-31.7-8%--0.5
$-0.00

Current Fair Value

112% downside

Overvalued by 112% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$902,323.00
Enterprise Value$1.02 Million
Earnings per Share$0
Beta-1.97
Outstanding Shares83,548,469

Return

Return on Equity7.77%ROE
Return on Assets-161.07%
Return on Invested Capital20.76%

Valuation & Multiples

P/E Ratio-31.67P/E Ratio
PEG11.79PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-18.35
Enterprise Value to Net Income-50
Total Debt to Enterprise0.12
Debt to Equity-0.46Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 14, 2026
EPS
$0.00
Reported
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nu-Med Plus, Inc.

2 employees
CEO: William R. Colvin

Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such a...